tiprankstipranks
Radiopharm Theranostics Limited (AU:RAD)
ASX:RAD
Australian Market
RAD
Radiopharm Theranostics Limited
RESEARCH TOOLSreports

Radiopharm Theranostics Limited (RAD) Stock News & Sentiment

24 Followers
Radiopharm Director Adjusts Share and Option Holdings
Premium
Company Announcements
Radiopharm Director Adjusts Share and Option Holdings
10d ago
RAD
Buy Rating on RADX Driven by Promising RAD 101 Phase 2b Imaging Data and Clear 2026 Clinical Milestones
Premium
Ratings
Buy Rating on RADX Driven by Promising RAD 101 Phase 2b Imaging Data and Clear 2026 Clinical Milestones
15d ago
RADX
Radiopharm’s RAD101 Hits 90% Concordance in Phase 2b Brain Metastases Trial
Premium
Company Announcements
Radiopharm’s RAD101 Hits 90% Concordance in Phase 2b Brain Metastases Trial
17d ago
RAD
Radiopharm Theranostics to spotlight oncology pipeline at NWR Virtual Healthcare Conference
Premium
Company Announcements
Radiopharm Theranostics to spotlight oncology pipeline at NWR Virtual Healthcare Conference
22d ago
RAD
Radiopharm Theranostics Narrows Asset Base as Half-Year Loss Widens, Increases Stake in MD Anderson JV
Premium
Company Announcements
Radiopharm Theranostics Narrows Asset Base as Half-Year Loss Widens, Increases Stake in MD Anderson JV
1M ago
RAD
Radiopharm’s New 161Tb-RAD402 Trial Puts AU:RAD in Focus for Prostate Cancer Investors
Premium
Company Announcements
Radiopharm’s New 161Tb-RAD402 Trial Puts AU:RAD in Focus for Prostate Cancer Investors
2M ago
RAD
Radiopharm Theranostics Posts Solid Cash Runway and Positive Interim Data for Lead Brain Metastases Imaging Agent
Premium
Company Announcements
Radiopharm Theranostics Posts Solid Cash Runway and Positive Interim Data for Lead Brain Metastases Imaging Agent
2M ago
RAD
More AU:RAD News >

RAD News on the Web

Radiopharm gets DSMC recommendation to advance 177Lu-RAD202 to next dose
TipRanks News
Bullish
Health Check: US military top brass warms to Aussie blood platelet freezing method
StockHead
Neutral
Radiopharm Director Adjusts Share and Option Holdings
TipRanks News
Neutral
Inside Biotech: Radiopharm advances RAD 402 into clinic with first patient dosed in Phase 1 trial
Proactive Investors
Bullish
Radiopharm advances RAD 402 into clinic with first patient dosed in Phase 1 trial
Proactive Investors
Bullish
Buy Rating on RADX Driven by Promising RAD 101 Phase 2b Imaging Data and Clear 2026 Clinical Milestones
TipRanks News
Bullish
Biotech Alert: Searches spiking for these stocks today
TipRanks News
Neutral
$10,000 invested in this ASX healthcare share a year ago is now worth $36,500
The Motley Fool
Bullish

News Score - Last 7 Days

Neutral
AU:RAD
Sector Average
Media Buzz
This Week2 articles
Weekly Average3 articles
News Sentiment
This Week100%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AU:RAD’s Media Buzz Sentiment?
2 articles about AU:RAD were published this week. In an average week, 3 articles are published.
    What is AU:RAD’s weekly average amount of articles?
    In an average week, 3 articles about AU:RAD are published.
      What is AU:RAD’s News Sentiment?
      100% of articles about AU:RAD were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        NBIXNeurocrine
        STAAStaar Surgical
        AORTArtivion
        OWLTOwlet
        HUMHumana
        Showing the stocks with the most bullish news sentiment over the past week